Recombinant Factor VIIa in Severe Uremic Bleeding

Thromb Haemost 1998; 80(02): 353
DOI: 10.1055/s-0037-1615210

Letters to the Editor

Schattauer GmbH

Tom Révész

¹Department of Haematology

,

Bert Arets

²Pulmonology and Intensive Care

,

Marc Bierings

¹Department of Haematology

,

Cor van den Bos

¹Department of Haematology

,

Els Duval

³Intensive Care, Wilhelmina Children’s Hospital, University of Utrecht, The Netherlands

References
1 Ingerslev J, Feldstedt M, Sindet-Petersen S. Control of haemostasis with recombinant factor VIIa in a patient with inhibitor to factor VIII.. Lancet 1991; 1: 831-1.
2 Kristensen J, Killander A, Hippe E, Helleberg C, Ellegard J, Holm M, Kutti J, Mellquist UH, Johansson JE, Glazer S, Hedner U. Clinical experience with recombinant factor VIIa in patients with thrombocytopenia.. Haemostasis 1996; 26: 159-64.
3 Tengborn L, Petruson B. A patient with Glanzmann thrombasthenia and epistaxis successfully treated with recombinant factor VIIa.. Thromb Haemost 1996; 75: 981-2.
4 Key NS. Efficacy of recombinant factor VIIa (rFVIIa) when administered in the home to control joint, muscle and mucocutaneous bleeds in hemophiliacs with inhibitors (abstr).. XVIth Congress of the Int Soc Thromb Haemost 1997.
5 Rabelink TJ, Zwaginga JJ, Koomans HA, Sixma JJ. Thrombosis and hemostasis in renal disease.. Kidney Int 1994; 46: 287-96.
6 Monroe DM, Hoffman M, Oliver JA, Roberts HR. Platelet activity of high-dose factor VIIa is independent of tissue factor.. Brit J Haematol 1998; 99: 542-7.